CoChat

The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study

Open access
Mortimer, Kevin, Lesosky, Maia, García-Marcos, Luis, Asher, M. Innes, Pearce, Neil, Ellwood, Eamon, Bissell, Karen, El Sony, Asma, Ellwood, Philippa, Marks, Guy B., Martínez-Torres, Antonela, Morales, Eva, Perez-Fernandez, Virginia, Robertson, Steven, Rutter, Charlotte E., Silverwood, Richard J., Strachan, David P., Chiang, Chen-Yuan · 2022 · European Respiratory Journal
Cited by 167

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Aims: Asthma, hay fever and eczema are three common chronic conditions. There have been no recent multi-country data on the burden of these three conditions in adults; the aims of this study are to fill this evidence gap. Methods: The Global Asthma Network Phase I is a multi-country cross-sectional population-based study using the same core methodology as the International Study of Asthma and Allergies in Childhood Phase III. It provides data on the burden of asthma, hay fever and eczema in children and adolescents, and, for the first time, in their parents/guardians. Results: Data were available from 193 912 adults (104 061 female; mean±sd age 38±7.5 years) in 43 centres in 17 countries. The overall prevalence (range) of symptoms was 6.6% (0.9–32.7%) for current wheeze, 4.4% (0.9–29.0%) for asthma ever, 14.4% (2.8–45.7%) for hay fever ever and 9.9% (1.6–29.5%) for eczema ever. Centre prevalence varied considerably both between countries and within countries. There was a moderate correlation between hay fever ever and asthma ever, and between eczema ever and hay fever ever at the centre level. There were moderate to strong correlations between indicators of the burden of disease reported in adults and the two younger age groups. Conclusion: We found evidence for a substantial burden of asthma, hay fever ever and eczema ever in the countries examined, highlighting the major public health importance of these diseases. Prevention strategies and equitable access to effective and affordable treatments for these three conditions would help mitigate the avoidable morbidity they cause.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/13993003.02865-2021

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 167

Metadata

Authors
Mortimer, K., Lesosky, M., García-Marcos, L., Asher, M. I., Pearce, N., Ellwood, E., Bissell, K., El Sony, A., Ellwood, P., Marks, G. B., Martínez-Torres, A., Morales, E., Perez-Fernandez, V., Robertson, S., Rutter, C. E., Silverwood, R. J., Strachan, D. P., & Chiang, C.-Y.
Venue
European Respiratory Journal
Published
2022-02-24
Volume
60
Issue
3
Pages
2102865
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W4213454188
Cited by
167
References
4
FWCI
17.07
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study. https://app.cochat.ai/papers/10.1183/13993003.02865-2021
The paper
Mortimer, K., Lesosky, M., García-Marcos, L., Asher, M. I., Pearce, N., Ellwood, E., Bissell, K., El Sony, A., Ellwood, P., Marks, G. B., Martínez-Torres, A., Morales, E., Perez-Fernandez, V., Robertson, S., Rutter, C. E., Silverwood, R. J., Strachan, D. P., & Chiang, C.-Y. (2022). The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study. European Respiratory Journal. https://doi.org/10.1183/13993003.02865-2021

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.